|
1
|
Esiashvili N, Goodman M and Marcus RB Jr:
Changes in incidence and survival of Ewing sarcoma patients over
the past 3 decades: Surveillance Epidemiology and End Results data.
J Pediatr Hematol Oncol. 30:425–430. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Womer RB, West DC, Krailo MD, Dickman PS,
Pawel BR, Grier HE, Marcus K, Sailer S, Healey JH, Dormans JP, et
al: Randomized controlled trial of interval-compressed chemotherapy
for the treatment of localized Ewing sarcoma: A report from the
Children's Oncology Group. J Clin Oncol. 30:4148–4154. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sayed D and Abdellatif M: MicroRNAs in
development and disease. Physiol Rev. 91:827–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lima RT, Busacca S, Almeida GM, Gaudino G,
Fennell DA and Vasconcelos MH: MicroRNA regulation of core
apoptosis pathways in cancer. Eur J Cancer. 47:163–174. 2011.
View Article : Google Scholar
|
|
5
|
Li S, Qiang Q, Shan H, Shi M, Gan G, Ma F
and Chen B: MiR-20a and miR-20b negatively regulate autophagy by
targeting RB1CC1/FIP200 in breast cancer cells. Life Sci.
147:143–152. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Danza K, Silvestris N, Simone G, Signorile
M, Saragoni L, Brunetti O, Monti M, Mazzotta A, De Summa S, Mangia
A, et al: Role of miR-27a, miR-181a and miR-20b in gastric cancer
hypoxia-induced chemoresistance. Cancer Biol Ther. 17:400–406.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamaguchi T, Iijima T, Wakaume R,
Takahashi K, Matsumoto H, Nakano D, Nakayama Y, Mori T, Horiguchi S
and Miyaki M: Underexpression of miR-126 and miR-20b in hereditary
and nonhereditary colorectal tumors. Oncology. 87:58–66. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chowdhury S, Ammanamanchi S and Howell GM:
Epigenetic targeting of transforming growth factor β receptor II
and implications for cancer therapy. Mol Cell Pharmacol. 1:57–70.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ikushima H and Miyazono K: TGFbeta
signalling: A complex web in cancer progression. Nat Rev Cancer.
10:415–424. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu Y, Kanwar SS, Patel BB, Oh PS, Nautiyal
J, Sarkar FH and Majumdar AP: MicroRNA-21 induces stemness by
downregulating transforming growth factor beta receptor 2 (TGFβR2)
in colon cancer cells. Carcinogenesis. 33:68–76. 2012. View Article : Google Scholar
|
|
11
|
Mishra S, Deng JJ, Gowda PS, Rao MK, Lin
CL, Chen CL, Huang T and Sun LZ: Androgen receptor and microRNA-21
axis downregulates transforming growth factor beta receptor II
(TGFBR2) expression in prostate cancer. Oncogene. 33:4097–4106.
2014. View Article : Google Scholar
|
|
12
|
Zhu X, Ozturk F, Liu C, Oakley GG and
Nawshad A: Transforming growth factor-β activates c-Myc to promote
palatal growth. J Cell Biochem. 113:3069–3085. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kawano M, Tanaka K, Itonaga I, Ikeda S,
Iwasaki T and Tsumura H: microRNA-93 promotes cell proliferation
via targeting of PTEN in Osteosarcoma cells. J Exp Clin Cancer Res.
34:762015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tanaka K, Kawano M, Itonaga I, Iwasaki T,
Miyazaki M, Ikeda S and Tsumura H: Tumor suppressive microRNA-138
inhibits metastatic potential via the targeting of focal adhesion
kinase in Ewing's sarcoma cells. Int J Oncol. 48:1135–1144.
2016.PubMed/NCBI
|
|
15
|
Kawano M, Tanaka K, Itonaga I, Iwasaki T
and Tsumura H: MicroRNA-301a promotes cell proliferation via PTEN
targeting in Ewing's sarcoma cells. Int J Oncol. 48:1531–1540.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
Downing JR, et al: MicroRNA expression profiles classify human
cancers. Nature. 435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu M, Trobridge P, Wang Y, Kanngurn S,
Morris SM, Knoblaugh S and Grady WM: Inactivation of TGF-β
signaling and loss of PTEN cooperate to induce colon cancer in
vivo. Oncogene. 33:1538–1547. 2014. View Article : Google Scholar
|
|
18
|
Mamiya T, Yamazaki K, Masugi Y, Mori T,
Effendi K, Du W, Hibi T, Tanabe M, Ueda M, Takayama T, et al:
Reduced transforming growth factor-beta receptor II expression in
hepatocellular carcinoma correlates with intrahepatic metastasis.
Lab Invest. 90:1339–1345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang B, Yang J and Xiao B: MicroRNA-20b
(miR-20b) promotes the proliferation, migration, invasion, and
tumorigenicity in esophageal cancer cells via the regulation of
phosphatase and tensin homologue expression. PLoS One.
11:e01641052016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park SL, Cho TM, Won SY, Song JH, Noh DH,
Kim WJ and Moon SK: MicroRNA-20b inhibits the proliferation,
migration and invasion of bladder cancer EJ cells via the targeting
of cell cycle regulation and Sp-1-mediated MMP-2 expression. Oncol
Rep. 34:1605–1612. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao HW, Li YW, Feng R, Yu JB, Li J, Zhang
Y, Li JC and Wang YX: TGF-β/Smad2/3 signal pathway involves in U251
cell proliferation and apoptosis. Gene. 562:76–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Choi J, Park SJ, Jo EJ, Lee HY, Hong S,
Kim SJ and Kim BC: Hydrogen peroxide inhibits transforming growth
factor-β1-induced cell cycle arrest by promoting Smad3 linker
phosphorylation through activation of Akt-ERK1/2-linked signaling
pathway. Biochem Biophys Res Commun. 435:634–639. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kawano M, Tanaka K, Itonaga I, Iwasaki T
and Tsumura H: c-Myc represses tumor-suppressive microRNAs, let-7a,
miR-16 and miR-29b, and induces cyclin D2-mediated cell
proliferation in Ewing's sarcoma cell line. PLoS One.
10:e01385602015. View Article : Google Scholar : PubMed/NCBI
|
